Target intelligence / Profile preview

Sympathetic fibers

Molecular classification
Other
01

Overview

Sympathetic fibers are the efferent axons of the sympathetic nervous system (SNS) that originate in the spinal cord and extend to various organs, glands, and blood vessels throughout the body. They primarily utilize norepinephrine as a neurotransmitter to mediate the 'fight-or-flight' response, increasing heart rate, inducing vasoconstriction, and mobilizing energy stores. While not a single molecular target, these fibers are the focus of therapeutic intervention in conditions characterized by sympathetic overactivity, such as resistant hypertension and chronic heart failure. Interventions include sympatholytic drugs that interfere with neurotransmission and procedural approaches like renal denervation, which targets the sympathetic nerves surrounding the renal arteries to lower systemic blood pressure. Because they are anatomical structures rather than specific proteins, they do not fit the traditional definition of a molecular drug target but remain a critical focal point for neuromodulation and cardiovascular pharmacology.

Other names
Sympathetic nervesAdrenergic fibersSympathetic nervous system fibersEfferent sympathetic pathways
02

Mechanism of action

Pharmacological agents typically modulate sympathetic fibers by inhibiting the release of norepinephrine, depleting neurotransmitter stores, or acting as false transmitters to reduce sympathetic outflow. Non-pharmacological approaches include surgical sympathectomy or catheter-based radiofrequency ablation (e.g., renal denervation) to physically disrupt the nerve fibers and reduce overactive signaling.

03

Biological functions

Fight-or-flight responseVasoconstrictionHeart rate regulationThermoregulationGlucose metabolism regulationGastrointestinal motility inhibition
04

Disease associations

HypertensionHeart failureCardiac arrhythmiaChronic kidney diseaseComplex regional pain syndromeHyperhidrosis
05

Safety considerations

Orthostatic hypotensionBradycardiaExercise intoleranceSexual dysfunction (e.g., retrograde ejaculation)Impaired thermoregulation
06

Interacting drugs

Guanethidine

5 more in the full profile.

07

Biomarkers

Muscle sympathetic nerve activity (MSNA)Plasma norepinephrine levelsNorepinephrine spillover rateHeart rate variability (HRV)

Beyond the preview

Go deeper on Sympathetic fibers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sympathetic fibers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call